halozyme therapeutics inc
(HALO:Consolidated Issue Listed on NASDAQ Global Select )
David A. Ramsay MBA
Chief Financial Officer and Vice President, Halozyme Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. David A. Ramsay, MBA, has been an Executive Advisor of NexDx, Inc. since January 2012. Mr. Ramsay has been the Chief Financial Officer of Halozyme Therapeutics, Inc. since May 23, 2013 and serves as its Vice President. He served as Vice President of Corporate Development of Halozyme Therapeutics, Inc. since May 15, 2009 and served as its Secretary. He served as the Chief Financial Officer of Halozyme Therapeutics Inc. (formerly Global Yacht Services, Inc.) from March ...
11388 Sorrento Valley RoadPhone: 858-794-8889
San Diego, California 92121
Board Members Memberships*
Independent Director, Chairman of Audit Committee, Member of Nominating & Governance Committee and Member of Compensation Committee
University of California Berkeley
University of Pennsylvania - The Wharton School
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Yongfeng Zhang Ph.D.||Chief Executive Officer, Chief Science Officer and Director|
Amphastar Pharmaceuticals, Inc.
|$1.4M||Compensation as of Fiscal Year 2014.|